20200311 Resultats 2019 EN
Category: Press release
Transgene and BioInvent to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
20200303 BT-001 presentations EN
First Patient Dosed with Transgene’s Oncolytic Virus TG6002, Administered by Intrahepatic Artery Infusion in Colorectal Cancer with Liver Metastases
20200220 PR FPI 6002.03 EN
Transgene and NEC Start Two Clinical Trials with TG4050, an individualized AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
20200107 PR TG4050 FPI – EN
Transgene Announces Financial Calendar for 2020
20191218 Financial calendar 2020 EN
Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer
20191212 PR TG4010_EN_results
Transgene and BioInvent announce compelling preclinical data for BT-001 in solid tumors
20191211 PR preclinical BT001 EN
Transgene Announces Investor Meetings for January 2020
20191209 PR Investors Meeting agenda 2020
Transgene Provides Q3 2019 Business Update, with Focus on Recently Announced Efficacy Results of TG4001
20191114 Résultats T3-2019 EN
Transgene Will Participate in the Jefferies 2019 London Healthcare Conference
20191022 – Transgene PR Jefferies EN